These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20200812)

  • 1. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study.
    Schütt M; Brinkhoff J; Drenckhan M; Lehnert H; Sommer C
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):449-52. PubMed ID: 20200812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
    Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topiramate on weight and metabolism in children with epilepsy.
    Li HF; Zou Y; Xia ZZ; Gao F; Feng JH; Yang CW
    Acta Paediatr; 2009 Sep; 98(9):1521-5. PubMed ID: 19508301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.
    Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K
    Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate induces weight loss and improves insulin sensitivity in dietary obese rats: comparison to sibutramine.
    Abo-Elmatty DM; Zaitone SA
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1187-95. PubMed ID: 22165681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of body weight and serum leptin levels in patients treated with topiramate.
    Theisen FM; Beyenburg S; Gebhardt S; Kluge M; Blum WF; Remschmidt H; Elger CE; Hebebrand J
    Clin Neuropharmacol; 2008; 31(4):226-30. PubMed ID: 18670246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topiramate use on body composition and resting metabolic rate in migraine patients.
    Yaman M; Ucok K; Demirbas H; Genc A; Oruc S; Karabacak H; Koyuncu G
    Neurol Sci; 2013 Feb; 34(2):225-9. PubMed ID: 22391675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of weight loss on high-molecular weight adiponectin in obese children.
    Martos-Moreno GÁ; Barrios V; Martínez G; Hawkins F; Argente J
    Obesity (Silver Spring); 2010 Dec; 18(12):2288-94. PubMed ID: 20339359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.
    Jürimäe J; Jürimäe T; Ring-Dimitriou S; LeMura LM; Arciero PJ; von Duvillard SP
    Metabolism; 2009 May; 58(5):638-43. PubMed ID: 19375586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.
    Okuyaz C; Kursel O; Komur M; Tamer L
    Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
    Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
    Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance.
    Chang HM; Lee HJ; Park HS; Kang JH; Kim KS; Song YS; Jang YJ
    Obesity (Silver Spring); 2010 Nov; 18(11):2105-10. PubMed ID: 20339362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate weight loss in migraine patients.
    Alberici A; Borroni B; Manelli F; Griffini S; Zavarise P; Padovani A; Dalla Volta G
    J Neurol Sci; 2009 Mar; 278(1-2):64-5. PubMed ID: 19084843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of leptin and high-molecular weight adiponectin in the general population of Japanese male adolescents.
    Nakatani H; Hirose H; Yamamoto Y; Saito I; Itoh H
    Metabolism; 2008 Feb; 57(2):157-62. PubMed ID: 18191043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively].
    Escobar L; Freire JM; Girón JA; Vázquez JM; Pajares M; Ortego J; Gavilán I; Chover AJ; Carrasco M; Epinosa R; Marín F; Aguilar M
    Rev Esp Med Nucl; 2000 Jun; 19(3):199-206. PubMed ID: 11062083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study.
    Verrotti A; Parisi P; Agostinelli S; Loiacono G; Marra F; Coppola G; Pisani LR; Gorgone G; Striano P; Pisani F; Belcastro V
    CNS Drugs; 2015 Feb; 29(2):163-9. PubMed ID: 25655110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.